Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Mara Renewables Corporation is currently managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners, meaning each pending application is being reviewed by a different individual. This distribution requires the legal team to tailor their approach to 2 different examiner styles for the matters.
Both of the 2 pending office actions are located within 1 distinct art unit. This concentration in a single art unit suggests that the company's Biotechnology & Pharmaceuticals innovations are being evaluated by the same technical division. Practitioners can benefit from this consistency by monitoring how this 1 distinct art unit interprets similar technical concepts across the applications.
TICHY, JENNIFER M.H. is the busiest examiner for this portfolio, holding 1 pending office action. Since TICHY, JENNIFER M.H. and the other distinct examiner each have 1 action, the workload is shared between them. Success in the 2 pending office actions will depend on addressing the specific requirements of both TICHY, JENNIFER M.H. and the other examiner within the shared framework of the 1 art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TICHY, JENNIFER M.H. | 1 | 64.9% | +34.5% |
| CLARKE, TRENT R | 1 | 42.0% | +24.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18894731 | METHODS FOR PRODUCING BIOMASS RICH IN DHA, PALMITIC ACID AND PROTEIN USING A EUKARYOTIC MICROORGANISM | TICHY, JENNIFER M.H. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17286449 | ADAPTATION AND PROCESS OPTIMIZATION OF MICROORGANISMS FOR GROWTH IN HEMICELLULOSIC DERIVED CARBOHYDRATES | CLARKE, TRENT R | 35d |
| 18894731 | METHODS FOR PRODUCING BIOMASS RICH IN DHA, PALMITIC ACID AND PROTEIN USING A EUKARYOTIC MICROORGANISM | TICHY, JENNIFER M.H. | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18894731 | METHODS FOR PRODUCING BIOMASS RICH IN DHA, PALMITIC ACID AND PROTEIN USING A EUKARYOTIC MICROORGANISM | TICHY, JENNIFER M.H. | — | §101§112DP | Non-Final OA | — | Pending | Sep 24, 2024 |
| 17286449 | ADAPTATION AND PROCESS OPTIMIZATION OF MICROORGANISMS FOR GROWTH IN HEMICELLULOSIC DERIVED CARBOHYDRATES | CLARKE, TRENT R | 1651 | §103Other | Non-Final OA | 35d | Pending | Apr 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial